(Q34750023)

4 August 2017

1 reference

title

Immunological mechanisms and the spectrum of psychiatric syndromes in Alzheimer's disease (English)

1 reference

4 August 2017

1 reference

Eikelenboom P

1

1 reference

4 August 2017

Hoogendijk WJ

series ordinal

2

1 reference

4 August 2017

Jonker C

series ordinal

3

1 reference

4 August 2017

van Tilburg W

series ordinal

4

1 reference

4 August 2017

language of work or name

1 reference

1 September 2002

1 reference

Journal of Psychiatric Research

4 August 2017

published in

1 reference

4 August 2017

volume

36

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

269-280

1 reference

Inflammatory mechanisms in Alzheimer's disease: implications for therapy

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Inflammation and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Microglia, amyloid and dementia in alzheimer disease. A correlative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Passage of cytokines across the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

The syntax of immune-neuroendocrine communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

In-vivo measurement of activated microglia in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Alterations in immunocompetence during stress, bereavement, and depression: focus on neuroendocrine regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

The role of complement and activated microglia in the pathogenesis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Do delirium and Alzheimer's dementia share specific pathogenetic mechanisms?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Delirium risk factors in elderly hospitalized patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Delirium, a syndrome of cerebral insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Application of DSM-III-R criteria for major depressive episode to elderly subjects with and without dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Depressive symptoms and risk of Alzheimer's disease in more highly educated older people.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Acute-phase proteins in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Increased activity of surviving locus ceruleus neurons in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Predisposing and precipitating factors for delirium in hospitalized older patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Life events, depressive symptoms, and immune function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Mood and motivation disturbance in elderly subjects with and without dementia: a replication study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Is depression a risk factor for dementia or cognitive decline? A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Immunological indices in the cerebrospinal fluid of patients with presenile dementia of the Alzheimer type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Cytokines and the brain: implications for clinical psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

The acute phase response: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

A review on the acute phase response in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Acute delirium and functional decline in the hospitalized elderly patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Experimental immunomodulation, sleep, and sleepiness in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Interleukin-1 beta decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Cytokine-associated emotional and cognitive disturbances in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

7 January 2021

Delirium in dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Complement activation by beta-amyloid in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Circulating cytokines in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Tryptophan depletion in SSRI-recovered depressed outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

The immune-neuro-link and the macrophage: postcardiotomy delirium, HIV-associated dementia and psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

IL-4, IL-10 and IL-13 modulate A beta(1--42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Update on the neuropathogenesis of delirium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Tryptophan degradation and immune activation in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Neuroendocrine-immune system interactions and autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

7 January 2021

Epidemiology of delirium: an overview of research issues and findings

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

7 January 2021

Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

7 January 2021

The Dexamethasone Suppression Test in Alzheimer's Disease and Major Depression: Relationship to Dementia Severity, Depression, and CSF Monoamines

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

7 January 2021

The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900006-7

7 January 2021

10.1016/S0022-3956(02)00006-7

Identifiers

DOI

1 reference

4 August 2017

1 reference